source
- Sarepta tumbles as its gene therapy sales decline furtherEven though Elevidys beat Wall Street expectations, analysts expect investor focus to shift toward Sarepta's early-stage RNA drugs.BioPharma Dive · 3mo ago↗ source
- Key takeaways from WHO briefing on hantavirus cruise ship outbreakHere are key takeaways from a WHO briefing on the hantavirus outbreak aboard a cruise ship.STAT · 3mo ago↗ source
- Women With Bladder Cancer Face Diagnostic Delays as Symptoms Mimic UTIs, Experts WarnTimothy N. Clinton, MD, and Stephanie A. Berg, DO, discuss gender differences in bladder cancer during Bladder Cancer Awareness Month.onclive · 3mo ago↗ source